
==== Front
JA Clin Rep
JA Clin Rep
JA Clinical Reports
2363-9024
Springer Berlin Heidelberg Berlin/Heidelberg

39222132
737
10.1186/s40981-024-00737-w
Case Report
Neuraxial anesthesia for patients with severe pulmonary arterial hypertension undergoing urgent open abdominal surgeries: two case reports
Yamada Shuhei
Takise Yoshiaki
Sekiya Yuri
Masuda Yuya
Misonoo Yoshi
Wakaizumi Kenta
Suhara Tomohiro
Morisaki Hiroshi
http://orcid.org/0000-0003-0918-4240
Kato Jungo jungo-k@a2.keio.jp

Yamada Takashige
https://ror.org/02kn6nx58 grid.26091.3c 0000 0004 1936 9959 Department of Anesthesiology, Keio University School of Medicine, Tokyo, 1608582 Japan
2 9 2024
2 9 2024
12 2024
10 5214 7 2024
25 8 2024
26 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Background

There is no consensus regarding the choice of anesthetic method for patients with pulmonary hypertension (PH). We report two cases in which neuraxial anesthesia was safely performed without general anesthesia during open abdominal surgery in patients with severe PH.

Case presentation

Case 1: A 59-year-old woman had an atrial septal defect and a huge abdominal tumor with a mean pulmonary arterial pressure (PAP) of 39 mmHg and pulmonary vascular resistance (PVR) of 3.5 Wood units. Case 2: A 23-year-old woman who had hereditary pulmonary artery hypertension (mean PAP, 65 mmHg; PVR, 16.45 Wood units). Both patients underwent open abdominal surgery under neuraxial anesthesia without circulatory collapse with intraoperative administration of vasoconstrictors.

Conclusion

Although anesthetic care must be personalized depending on the pathology and severity of PH, neuraxial anesthesia may be an option for patients with severe PH undergoing abdominal surgery.

Keywords

Pulmonary hypertension
Adult congenital heart disease
Noncardiac surgery
Neuraxial anesthesia
issue-copyright-statement© The Japanese Society of Anesthesiologists 2024
==== Body
pmcBackground

Pulmonary hypertension (PH), which is defined as an elevated mean pulmonary arterial pressure (PAP) > 20 mmHg at rest [1], poses great challenges in anesthetic management. Patients with severe PH are reported to be at higher risk of perioperative morbidities, such as congestive heart failure, hemodynamic instability, sepsis, and right heart failure [2]. These morbidities lead to the high perioperative mortality in the range of 4 to 24% in patients with severe PH [3]. Currently, there is no consensus on the choice of anesthetic method for patients with severe PH. Here, we present two patients with severe PH with different pathologies who underwent urgent open abdominal surgery. In both patients, successful circulatory management was achieved under neuraxial anesthesia.

Case presentation

Case 1

A 59-year-old woman (height, 163 cm; weight, 65 kg) with an untreated atrial septal defect (ASD) was hospitalized with complaints of abdominal distention, leg edema, and dyspnea. Computed tomography revealed a giant ovarian tumor occupying the entire abdominal cavity (Fig. 1A). An urgent gynecological surgery was scheduled. Laboratory data showed an elevated brain natriuretic peptide (BNP) of 621 pg/mL, and a preoperative right heart catheter examination revealed severe PH, presumably associated with ASD, with a mean PAP of 39 mmHg, a high pulmonary blood flow to systemic blood flow ratio (Qp/Qs) of 2.7, and high pulmonary vascular resistance (PVR) 3.5 Wood units. Transesophageal echocardiography showed a large ASD (diameter, 26 mm; secondary type; Fig. 1B) with a left-to-right shunt, dilated right atrium and ventricle, moderate pulmonary regurgitation, and moderate tricuspid regurgitation (TR). Given the limited free space in the abdominal cavity owing to the large tumor size, open surgery was chosen over the laparoscopic approach. Considering the potential hazardous effects of general anesthesia and mechanical ventilation on pulmonary and systemic circulation in case of severe PH and the risk of regurgitation of gastric contents during intubation, we decided to avoid general anesthesia and performed combined spinal-epidural anesthesia (CSEA).Fig. 1 Preoperative images and intraoperative anesthetic course in Case 1. A Sagittal view of T2-weighted MRI showing a large ovarian tumor (38 × 20 × 37 cm). B Atrial septal view of transthoracic echocardiography. Atrial septal deficit with 26-mm diameter and left–right shunt were identified. RA, right atrium; LA, left atrium; ASD, atrial septal deficit. C Hemodynamic parameters during open abdominal surgery under neuraxial anesthesia. After epidural and subarachnoid anesthesia, surgery started while monitoring ABP, CVP, and PAP. Contents in the tumor were aspirated in 500-mL increments, and a total of 15 L of serous fluid was aspirated over 30 min within the period (*). CVP and PAP decreased, whereas ABP and pulse pressure increased with the aspiration. × , anesthesia start/end; EDB, epidural block; SA, spinal anesthesia; ◎, surgery start/end

Upon arrival in the operating room, standard vital monitors, including an electrocardiogram, a pulse oximeter, and a noninvasive blood pressure monitor, were placed. The peripheral oxygen saturation (SpO2) before the administration of oxygen was 93 to 97%. To counteract the hypotension caused by the neuraxial block, an intravenous infusion of phenylephrine (1 mg/h) was initiated before starting CSEA. An epidural catheter was placed in the T11–12 interspace. Consequently, spinal anesthesia was induced at the L4–5 interspace, and 2.5 mL of 0.5% isobaric bupivacaine was administered intrathecally. Successful sensory blockade above the T4 level was confirmed through a cold test with an alcohol swab. Furthermore, an arterial catheter was inserted into the right radial artery, and a pulmonary artery catheter was inserted under local anesthesia to monitor arterial blood pressure (ABP), PAP, and central venous pressure (CVP), respectively. Surgery was initiated after achieving conscious sedation with boluses of midazolam and fentanyl and a target-controlled infusion of propofol. Although additional boluses of phenylephrine were required to maintain the ABP, however, the CVP and PAP remained stable. In total, 15 L of intra-tumor fluid was carefully aspirated over 30 min. Meanwhile, the ABP gradually increased, whereas the mean PAP and CVP decreased. The phenylephrine infusion was discontinued after aspiration (Fig. 1C). The tumor was completely resected, and the operation was completed within 90 min. The intraoperative fluid infusion volume, blood loss, and urine output were 823, 50, and 300 mL, respectively. The postoperative course was uneventful with no remarkable postoperative pain or hemodynamic derangement. The patient was discharged from the hospital on postoperative day (POD) 9.

Case 2

A 25-year-old woman (height, 151 cm; weight, 42 kg) with hereditary pulmonary arterial hypertension was admitted to our hospital with upper abdominal pain. An acute cholecystitis was diagnosed, and the surgical team planned an emergency cholecystectomy. The right heart catheter examination performed 5 months earlier showed a high PAP of 92/48 (mean, 65) mmHg, a significantly elevated PVR of 16.45 Wood units, and a cardiac index of 2.65 L/min/m2. Despite home oxygen therapy (2 L/min) and continuous infusion of treprostinil at 220 ng/kg/min into the right atrium (Fig. 2A), she had been suffering from dyspnea on effort. Transthoracic echocardiography performed after hospitalization revealed a markedly enlarged right ventricle compressing left ventricle (Fig. 2B). Considering the limited reserve of the pulmonary circulation, the multidisciplinary team decided to perform open abdominal surgery under epidural anesthesia, avoiding general anesthesia.Fig. 2 Preoperative assessment and intraoperative anesthetic course in Case 2. A Preoperative chest radiography after insertion of the central venous catheter. Central venous catheter (i) was inserted from the right internal jugular vein for perioperative catecholamine infusion, in addition to Hickman catheter (ii) inserted from the left internal jugular vein into the right atrium for a continuous infusion of a vasodilator. B The transgastric mid-papillary short-axis view of the preoperative transesophageal echocardiography. Right ventricular enlargement and compression of the left ventricle were identified. RV, right ventricle; LV, left ventricle. C Hemodynamic parameters during open abdominal surgery under neuraxial anesthesia: During surgery, pethidine and fentanyl were administered intravenously for stimuli of peritoneal traction. × , anesthesia start/end; EDB, epidural block; ◎, surgery start/end

In the operating room, the baseline SpO2 with 2 L/min of oxygen via nasal cannula was 95 to 97%. An epidural catheter was inserted from T6 to 7, and 10 mL of 1% lidocaine was administered. In addition, an arterial catheter through the right radial artery and a central venous catheter through the right internal jugular vein were secured under local anesthesia. After confirming sensory loss above the T4 level, surgery was initiated (Fig. 2C). Intraoperatively, as the patient occasionally complained of discomfort, bolus infusions of 50 µg of fentanyl and 35 mg of pethidine in total, and an additional epidural injection of 10 mL of 2% lidocaine, were required. The intraoperative ABP was generally maintained by continuous administrations of phenylephrine (1–2 mg/h) and noradrenaline (0.1–0.15 µg/kg/min). The surgery was completed in 88 min. The intraoperative fluid infusion volume, blood loss, and urine output were 646, 90, and 150 mL, respectively. Postoperative pain was well-controlled with patient-controlled epidural analgesia. Her hemodynamic status remained stable postoperatively, and noradrenaline administration was discontinued on POD1. The patient recovered uneventfully and was discharged from the hospital on POD14.

Discussion

Severe PH complicates anesthetic management by potentially triggering a vicious cycle as follows: (1) worsening of right heart failure, (2) reduced forward flow to the left heart, and (3) decreased cardiac output and reduced coronary perfusion, further deteriorating right heart failure [4]. Therefore, the major goals of perioperative hemodynamic management for patients with severe PH include avoiding further elevation of PVR and maintaining cardiac contractility and systemic perfusion pressure.

Concerning abdominal surgeries, the choice of surgical approach may have a great impact on hemodynamics in patients with severe PH. In both of our cases, multidisciplinary discussions eventually led to the selection of the open approach over the laparoscopic approach. Despite previous reports demonstrating successful laparoscopic surgeries for patients with severe PH [5–7], the implementation of pneumoperitoneum in the laparoscopic approach potentially worsens PH through several mechanisms, such as abdominal distention, hypercapnia, acidemia, and reduced lung compliance [8, 9]. Although the invasiveness and postoperative pain associated with the open approach can be deleterious, these disadvantages were successfully overcome by postoperative epidural analgesia in both of our cases. Thus, an open approach can be an option for patients with severe PH provided that excellent postoperative pain control can be achieved with epidural analgesia.

Several predisposing factors have been proposed for predicting poor postoperative outcomes after noncardiac surgeries in patients with severe PH. These include age ≥ 75 years, New York Heart Association functional classification ≥ II, systolic PAP ≥ 70 mmHg, CVP > 7 mmHg, emergency cases, and moderate-to-high-risk surgical procedures [10–13]. In the case of adult congenital heart disease with PH, various postoperative risk stratification models for noncardiac surgeries based on multiple factors, such as physical status, complexity of the cardiac lesion, age, other comorbidities, and risk of the surgical procedure, have also been validated [14]. Recently, Hassan et al. proposed a simple composite risk assessment tool for patients with PH undergoing noncardiac surgery that combines patient-level and procedural variables (Table 1) [15]. Based on these risk stratifications, our cases were both classified into the high-risk group. Table 1 A simple perioperative risk assessment tool for patients with pulmonary hypertension [15]

Variables	Score	
WHO functional class	
 I or II	0	
 III or IV	1	
6-min walking distance	
 > 400 m	0	
 ≦400 m	1	
BNP or NT-proBNP	
 BNP < 50 ng/L or NT-proBNP < 300 ng/L	0	
 BNP ≧ 50 ng/L or NT-proBNP ≧ 300 ng/L	1	
AHA/ACC procedural risk	
 Low	0	
 Elevated	4	
0–2, low risk; 3, intermediate risk; 4–7, high risk

Nevertheless, the pathology of PH can change dynamically in response to anesthetic and surgical interventions. As for adult congenital heart diseases with intracardiac shunts, such as in Case 1, a worsening of PH may increase the right-to-left shunt, immediately leading to systemic deoxygenation. Therefore, regardless of the preoperative risk estimation, close perioperative monitoring, including ABP, CVP, pulse oximetry (SpO2), PAP, and echocardiography, should always be considered in patients with severe PH. Although the aspiration of 15 L of intra-tumor fluid over 30 min did not result in major hemodynamic changes in Case 1, such a radical surgical maneuver should have been carefully performed with meticulous monitoring of the aforementioned hemodynamic parameters.

The choice of anesthetic method remains a topic of discussion for patients with severe PH. Although general anesthesia can provide excellent depth of sedation, muscle relaxation, and analgesia, the most commonly used general anesthetics have hemodynamically unfavorable effects on PH circulation, such as reductions in cardiac contractility, systemic vascular resistance (SVR), and preload [6, 16]. In addition, an increase in airway pressure caused by mechanical ventilation potentially aggravates PH by elevating the PVR [17]. Moreover, sympathetic responses associated with intubation and extubation may have detrimental effects on the PH circulation. However, some guidelines recommend not using spinal anesthesia in patients with severe PH because of concerns regarding rapid hemodynamic derangements, including the rapid reduction of SVR and preload [13, 18]. Despite these recommendations, the prophylactic use of phenylephrine infusion successfully counteracted spinal anesthesia-induced hypotension in Case 1. Hemodynamically, epidural anesthesia shares similar disadvantages with spinal anesthesia but generally has a milder and slower onset of sympathetic inactivation. However, in Case 2, a higher dose of phenylephrine and noradrenaline infusion were required to maintain the ABP. The severer PH in Case 2 (mPAP, 39 mmHg, PVR 3.5 Wood units in Case 1; mPAP, 65 mmHg, PVR 16.5 Wood units in Case 2) may have contributed to the more pronounced hemodynamic effects of neuraxial anesthesia.

Vasoactive drugs are often necessary to counter the hypotension associated with anesthesia in patients with severe PH. However, the selection of vasoactive drugs should be determined with special caution. In our case, maintenance of ABP was achieved with vasopressors, including phenylephrine and noradrenaline, without any signs of hemodynamic derangement. However, these vasopressors potentially disrupt circulation in PH by increasing PVR via the action of alpha-adrenergic receptors in the pulmonary vasculature [13]. Although there are few data, vasopressin can be an option in some cases of severe PH because of its systemic vasopressive effect without increasing PVR [3, 11]. The use of inotropes, including dobutamine, PDE-III inhibitors, adrenaline, and/or inhaled nitric oxide, should be considered in patients with progressive right ventricle dysfunction.

Collectively, although the use of vasopressors should be optimized depending on the severity, pathophysiology, and responsiveness to PH, neuraxial anesthesia may be an option for patients with severe PH undergoing abdominal surgery. Nevertheless, rigorous hemodynamic monitoring and multidisciplinary collaboration are mandatory for the safe perioperative management of patients with severe PH.

Abbreviations

PH Pulmonary hypertension

PAP Pulmonary arterial pressure

ASD Atrial septal defect

BNP Brain natriuretic peptide

RHC Right heart catheter

Qp/Qs Pulmonary blood flow to systemic blood flow ratio

PVR Pulmonary vascular resistance

TR Tricuspid regurgitation

CSEA Combined spinal-epidural anesthesia

SpO2 Peripheral oxygen saturation

ABP Arterial blood pressure

CVP Central venous pressure

POD Postoperative day

SpO2 Pulse oximetry

SVR Systemic vascular resistance

RA Right atrium

LA Left atrium

EDB Epidural block

SA Spinal anesthesia

RV Right ventricle

LV Left ventricle

Acknowledgements

None

Authors’ contributions

SY, YT, and JK designed this case report, wrote the manuscript, and prepared the images and figures. YS, YMa, YMi, KW, TS, HM, and TY helped confirm the accuracy and integrity of the manuscript.

Funding

None.

Availability of data and materials

The data in this case report are available from the corresponding author on reasonable requests.

Declarations

Ethics approval and consent to participate

In our institution, publication of case reports is exempted from ethics committee approval.

Consent for publication

The written informed consents were obtained from the patients for publication of this case report and accompanying images.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Humbert M Kovacs G Hoeper MM Badagliacca R Berger RMF Brida M 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Heart J 2022 43 3618 3731 10.1093/eurheartj/ehac237 36017548
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43:3618–731.36017548 10.1093/eurheartj/ehac237
2. Kaw R Pasupuleti V Deshpande A Hamieh T Walker E Minai OA Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery Respir Med 2011 105 619 624 10.1016/j.rmed.2010.12.006 21195595
Kaw R, Pasupuleti V, Deshpande A, Hamieh T, Walker E, Minai OA. Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery. Respir Med. 2011;105:619–24.21195595 10.1016/j.rmed.2010.12.006
3. Sarkar MS Desai PM Pulmonary hypertension and cardiac anesthesia: anesthesiologist’s perspective Ann Card Anaesth 2018 21 116 122 10.4103/aca.ACA_123_17 29652270
Sarkar MS, Desai PM. Pulmonary hypertension and cardiac anesthesia: anesthesiologist’s perspective. Ann Card Anaesth. 2018;21:116–22.29652270 10.4103/aca.ACA_123_17
4. Price LC Martinez G Brame A Pickworth T Samaranayake C Alexander D Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement Br J Anaesth 2021 126 774 790 10.1016/j.bja.2021.01.005 33612249
Price LC, Martinez G, Brame A, Pickworth T, Samaranayake C, Alexander D, et al. Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement. Br J Anaesth. 2021;126:774–90.33612249 10.1016/j.bja.2021.01.005
5. Wang J Lu J Anesthesia for pregnant women with pulmonary hypertension J Cardiothorac Vasc Anesth 2021 35 2201 2211 10.1053/j.jvca.2020.06.062 32736999
Wang J, Lu J. Anesthesia for pregnant women with pulmonary hypertension. J Cardiothorac Vasc Anesth. 2021;35:2201–11.32736999 10.1053/j.jvca.2020.06.062
6. Shelly MP Robinson AA Hesford JW Park GR Haemodynamic effects following surgical release of increased intra-abdominal pressure Br J Anaesth 1987 59 800 805 10.1093/bja/59.6.800 3300756
Shelly MP, Robinson AA, Hesford JW, Park GR. Haemodynamic effects following surgical release of increased intra-abdominal pressure. Br J Anaesth. 1987;59:800–5.3300756 10.1093/bja/59.6.800
7. Atkinson TM Giraud GD Togioka BM Jones DB Cigarroa JE Cardiovascular and ventilatory consequences of laparoscopic surgery Circulation 2017 135 700 710 10.1161/CIRCULATIONAHA.116.023262 28193800
Atkinson TM, Giraud GD, Togioka BM, Jones DB, Cigarroa JE. Cardiovascular and ventilatory consequences of laparoscopic surgery. Circulation. 2017;135:700–10.28193800 10.1161/CIRCULATIONAHA.116.023262
8. Alviar CL Miller PE McAreavey D Katz JN Lee B Moriyama B Positive pressure ventilation in the cardiac intensive care unit J Am Coll Cardiol 2018 72 1532 1553 10.1016/j.jacc.2018.06.074 30236315
Alviar CL, Miller PE, McAreavey D, Katz JN, Lee B, Moriyama B, et al. Positive pressure ventilation in the cardiac intensive care unit. J Am Coll Cardiol. 2018;72:1532–53.30236315 10.1016/j.jacc.2018.06.074
9. Höstman S Borges JB Suarez-Sipmann F Ahlgren KM Engström J Hedenstierna G THAM reduces CO2-associated increase in pulmonary vascular resistance - an experimental study in lung-injured piglets Crit Care 2015 19 331 10.1186/s13054-015-1040-4 26376722
Höstman S, Borges JB, Suarez-Sipmann F, Ahlgren KM, Engström J, Hedenstierna G, et al. THAM reduces CO2-associated increase in pulmonary vascular resistance - an experimental study in lung-injured piglets. Crit Care. 2015;19:331.26376722 10.1186/s13054-015-1040-4
10. Minai OA Yared JP Kaw R Subramaniam K Hill NS Perioperative risk and management in patients with pulmonary hypertension Chest 2013 144 329 340 10.1378/chest.12-1752 23880683
Minai OA, Yared JP, Kaw R, Subramaniam K, Hill NS. Perioperative risk and management in patients with pulmonary hypertension. Chest. 2013;144:329–40.23880683 10.1378/chest.12-1752
11. Olsson KM Halank M Egenlauf B Fistera D Gall H Kaehler C Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: updated recommendations from the Cologne Consensus Conference 2018 Int J Cardiol 2018 272S 46 52 10.1016/j.ijcard.2018.08.081 30190155
Olsson KM, Halank M, Egenlauf B, Fistera D, Gall H, Kaehler C, et al. Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018;272S:46–52.30190155 10.1016/j.ijcard.2018.08.081
12. Pilkington SA Taboada D Martinez G Pulmonary hypertension and its management in patients undergoing non-cardiac surgery Anaesthesia 2015 70 56 70 10.1111/anae.12831 25267493
Pilkington SA, Taboada D, Martinez G. Pulmonary hypertension and its management in patients undergoing non-cardiac surgery. Anaesthesia. 2015;70:56–70.25267493 10.1111/anae.12831
13. Rajagopal S Ruetzler K Ghadimi K Horn EM Kelava M Kudelko KT Evaluation and management of pulmonary hypertension in noncardiac surgery: a scientific statement from the American Heart Association Circulation 2023 147 1317 1343 10.1161/CIR.0000000000001136 36924225
Rajagopal S, Ruetzler K, Ghadimi K, Horn EM, Kelava M, Kudelko KT, et al. Evaluation and management of pulmonary hypertension in noncardiac surgery: a scientific statement from the American Heart Association. Circulation. 2023;147:1317–43.36924225 10.1161/CIR.0000000000001136
14. Nasr VG Markham LW Clay M DiNardo JA Faraoni D Gottlieb-Sen D Perioperative considerations for pediatric patients with congenital heart disease presenting for noncardiac procedures: a scientific statement from the American Heart Association Circ Cardiovasc Qual Outcomes 2023 16 e000113 10.1161/HCQ.0000000000000113 36519439
Nasr VG, Markham LW, Clay M, DiNardo JA, Faraoni D, Gottlieb-Sen D, et al. Perioperative considerations for pediatric patients with congenital heart disease presenting for noncardiac procedures: a scientific statement from the American Heart Association. Circ Cardiovasc Qual Outcomes. 2023;16:e000113.36519439 10.1161/HCQ.0000000000000113
15. Hassan HJ Housten T Balasubramanian A Simpson CE Damico RL Mathai SC A novel approach to perioperative risk assessment for patients with pulmonary hypertension ERJ Open Res 2021 7 3 00257 2021 10.1183/23120541.00257-2021 34291108
Hassan HJ, Housten T, Balasubramanian A, Simpson CE, Damico RL, Mathai SC, et al. A novel approach to perioperative risk assessment for patients with pulmonary hypertension. ERJ Open Res. 2021;7(3):00257–2021.34291108 10.1183/23120541.00257-2021
16. Gille J Seyfarth HJ Gerlach S Malcharek M Czeslick E Sablotzki A Perioperative anesthesiological management of patients with pulmonary hypertension Anesthesiol Res Pract 2012 2012 356982 23097665
Gille J, Seyfarth HJ, Gerlach S, Malcharek M, Czeslick E, Sablotzki A. Perioperative anesthesiological management of patients with pulmonary hypertension. Anesthesiol Res Pract. 2012;2012:356982.23097665
17. Nowroozpoor A Malekmohammad M Seyyedi SR Hashemian SM Pulmonary hypertension in intensive care units: an updated review Tanaffos 2019 18 180 207 32411259
Nowroozpoor A, Malekmohammad M, Seyyedi SR, Hashemian SM. Pulmonary hypertension in intensive care units: an updated review. Tanaffos. 2019;18:180–207.32411259
18. Meyer S McLaughlin VV Seyfarth HJ Bull TM Vizza CD Gomberg-Maitland M Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey Eur Respir J 2013 41 1302 1307 10.1183/09031936.00089212 23143546
Meyer S, McLaughlin VV, Seyfarth HJ, Bull TM, Vizza CD, Gomberg-Maitland M, et al. Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. Eur Respir J. 2013;41:1302–7.23143546 10.1183/09031936.00089212
